[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:head-and-neck-cutaneous-squamous-cell-carcinoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":27,"states":28},"Head and Neck Cutaneous Squamous Cell Carcinoma",3,[7,15,21],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07156227","Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma",[11],"Phase 1","RECRUITING","2026-08-26T02:17:44.240289Z","2026-06-04T01:30:07.902043Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT05747625","(89Zr Panitumumab) With PET\u002FCT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma",[11],"2026-08-26T02:16:01.910993Z","2026-05-05T02:43:27.856334Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT06662058","Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and\u002For Radiation",[],"2026-08-26T02:18:55.570428Z","2026-05-05T02:43:28.986718Z",[],[]]